Moreover, prevention of teratoma formation has been also evaluated by immunological treatment, using antibodies against different antigens such as SSEA-5, claudin-6, or using cytotoxic antibodies (Tang et al., 2011; Ben-David et al., 2013b; Wyles et al., 2014). This evidence concerns the gene CLDN6 and teratoma.